Home

Prioritize the right market opportunity

Latitude Discovery enables pre-commercial biopharma and medical device organizations to quickly assess potential market opportunities associated with therapy development for granular patient cohorts. By iteratively analyzing and reporting on real-world data, organizations can determine their total addressable market, gain insight into patient care pathways and better inform their product positioning for a stronger go-to-market strategy.

Prioritize the right market opportunity for patients.

Guide therapy development with meaningful intelligence

Latitude Discovery gives you an intuitive, iterative platform that can be used to:

Create customized patient cohorts

Easily build complex patient cohorts

Use any combination of hospital and medical claims data such as diagnoses or procedures to quickly identify patient populations that would benefit from your therapy.

Try now
Analyze and learn

Analyze, learn and optimize

View patient, geographical and payor characteristics related to your patient cohort, then refine your targeting to better align it with your business objectives.

Try now
Build claims data reports

Customize detailed claims reports

Generate time-based reports specific to your target patient cohort, then drag and drop custom diagnosis, procedure and prescription data elements to surface the most important information.

Try now

See it in action

Connect with us to explore our data.

Get a custom quote

Solutions tailored to your business

See pricing

Try us out

Grow your business faster.

Start a free trial

Get a clearer picture

With Latitude Discovery you can:

Harness real-world data

Harness real-world data

Get the specific real-world market intelligence you need today without having to pay for vast amounts of data that you won’t need until tomorrow.

Cut through complex data science

Cut through complex data science

Access claims data insights historically available only to data scientists. Latitude Discovery is intuitive enough for anyone to analyze cohorts from many different perspectives.

Streamline the path to FDA approval

Streamline the path to FDA approval

Free yourself from relying on analytics experts or third-party consultants. Get the insights you need in minutes, not days or weeks.

Accelerate your go-to-market strategy

Latitude Discovery enables you to:

Improve market opportunity selection

Dig into market-level reporting to gain real-time intelligence on the size of addressable patient and provider populations, clinical volumes, demographics and payor mix to ensure you’re selecting the opportunity that will have the greatest potential for success.

Create organizational alignment

Use flexible input methods to populate fields at the keyword and/or code level and self-service reporting to quickly validate existing answers – or ask new questions as information needs evolve along the therapy development lifecycle.

Inform programmatic decision making

Customize any of nine pre-built reports to understand the occurrence of all additional diagnoses and procedures associated with the patients and providers in your target population to inform clinical trial recruitment and endpoint selection.

See the big picture

Latitude Discovery provides even greater value when integrated with other data products to create comprehensive industry solutions and use-case specific solutions. Latitude Discovery complements other data products as part of these solutions:

Biopharma

Size market opportunities, engage clinical experts and identify provider and patient targets to speed up commercialization.

Learn more

Medical Devices

Ensure investments align with quantifiable market opportunities and optimize sales planning with targeted providers and patients.

Learn more

Frequently asked questions

    Latitude Discovery is a Definitive Healthcare product and patient cohort refinement and reporting tool that enables quick and intuitive market assessments for early-stage medical device, pharmaceutical, and biotechnology organizations.

    Latitude Discovery helps pre-commercial biopharma and medical device organizations quickly assess potential market opportunities associated with therapy development for granular patient cohorts. By iteratively analyzing and reporting on real-world data, organizations can determine their total addressable market, gain insight into patient care pathways, and better inform their product positioning for a stronger go-to-market strategy.

    Latitude Discovery was designed specifically for early-stage pharmaceutical and medical device companies to perform market sizing evaluations, understand the total addressable market and identify payor mix for initial market access assessment using real-world data.

    Further along in your new product development process?

    Latitude Reporting provides powerful context with access to provider reference and affiliation data, so you can plan for a successful market launch and maximize your opportunity prior to patent expiration.